Cargando…

Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine

BACKGROUND: A Phase 1-2b study of the blood stage malaria vaccine AMA1-C1/Alhydrogel was conducted in 336 children in Donéguébougou and Bancoumana, Mali. In the Phase 2 portion of the study (n = 300), no impact on parasite density or clinical malaria was seen; however, children who received the stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellis, Ruth D, Fay, Michael P, Sagara, Issaka, Dicko, Alassane, Miura, Kazutoyo, Guindo, Merepen A, Guindo, Aldiouma, Sissoko, Mahamadou S, Doumbo, Ogobara K, Diallo, Dapa
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036666/ https://www.ncbi.nlm.nih.gov/pubmed/21247484 http://dx.doi.org/10.1186/1475-2875-10-13

Ejemplares similares

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
por: Dicko, Alassane, et al.
Publicado: (2008)

Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
por: Dicko, Alassane, et al.
Publicado: (2008)

Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali
por: Kone, Abdoulaye K, et al.
Publicado: (2010)

Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
por: Dicko, Alassane, et al.
Publicado: (2007)

X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria
por: Guindo, Aldiouma, et al.
Publicado: (2007)

Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali
por: Coulibaly, Drissa, et al.
Publicado: (2014)

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village
por: Gaudart, Jean, et al.
Publicado: (2006)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
por: Dama, Souleymane, et al.
Publicado: (2018)

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial
por: Sagara, Issaka, et al.
Publicado: (2009)

“Spatial heterogeneity of environmental risk in randomized prevention trials: consequences and modeling”
por: Guindo, Abdoulaye, et al.
Publicado: (2019)

Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential
por: Gonçalves, Bronner P., et al.
Publicado: (2017)

Dynamics of Polymorphism in a Malaria Vaccine Antigen at a Vaccine-Testing Site in Mali
por: Takala, Shannon L, et al.
Publicado: (2007)

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
por: Greenwood, Brian, et al.
Publicado: (2017)

Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial
por: Thera, Mahamadou A, et al.
Publicado: (2006)

Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali
por: Diarra, Modibo, et al.
Publicado: (2021)

A Decline and Age Shift in Malaria Incidence in Rural Mali following Implementation of Seasonal Malaria Chemoprevention and Indoor Residual Spraying
por: Coulibaly, Drissa, et al.
Publicado: (2021)

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children
por: Travassos, Mark A., et al.
Publicado: (2015)

Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
por: Miura, Kazutoyo, et al.
Publicado: (2011)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
por: Tekete, Mamadou, et al.
Publicado: (2009)

Shifts in the clinical epidemiology of severe malaria after scaling up control strategies in Mali
por: Coulibaly, Drissa, et al.
Publicado: (2022)

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008)

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
por: Barry, Amadou, et al.
Publicado: (2018)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
por: Dicko, Alassane, et al.
Publicado: (2010)

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
por: Thera, Mahamadou A., et al.
Publicado: (2016)

Two-Year Scale-Up of Seasonal Malaria Chemoprevention Reduced Malaria Morbidity among Children in the Health District of Koutiala, Mali
por: Maiga, Hamma, et al.
Publicado: (2020)

Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
por: Ouattara, Amed, et al.
Publicado: (2010)

Extensive Ethnogenomic Diversity of Endothelial Nitric Oxide Synthase (eNOS) Polymorphisms
por: Thomas, Bolaji N., et al.
Publicado: (2013)

Patterns of malaria indices across three consecutive seasons in children in a highly endemic area of West Africa: a three times-repeated cross-sectional study
por: Ardiet, Denis-Luc, et al.
Publicado: (2014)

The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections
por: Weiss, Greta E., et al.
Publicado: (2010)

Repeated Artemisinin-Based Combination Therapies in a Malaria Hyperendemic Area of Mali: Efficacy, Safety, and Public Health Impact
por: Sagara, Issaka, et al.
Publicado: (2012)

Taux des plaquettes sanguines en phase intercritique et expressivité clinique de la drépanocytose dans un centre de référence de la drépanocytose au Mali
por: Diallo, Lamine, et al.
Publicado: (2022)

Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali
por: Traoré, Karim, et al.
Publicado: (2020)

A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study
por: Denoeud-Ndam, Lise, et al.
Publicado: (2015)

Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2014)

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2016)

Adapting malaria clinical trials infrastructure to implement COVID-19 epidemiology studies: Response to a public health emergency amid safe continuation of a research enterprise
por: Woodford, John, et al.
Publicado: (2022)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali
por: Maiga, Hamma, et al.
Publicado: (2016)

Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data
por: Sagara, Issaka, et al.
Publicado: (2014)

Diagnostic accuracy in field conditions of the sickle SCAN® rapid test for sickle cell disease among children and adults in two West African settings: the DREPATEST study
por: Segbena, Akueté Yvon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pfugji7a9u2lir5qbr1lmvt2pg